This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cho, N. L. Articles by Bertagnolli, M. M. Search for Related Content PubMed PubMed Citation Articles by Cho, N. L. Articles by Bertagnolli, M. M. Related Collections Oncogenesis Oncogenesis: Animal Models

Estrogen Receptors and ß Are Inhibitory Modifiers of Apc-Dependent Tumorigenesis in the Proximal Colon of Min/+ Mice

Departments of ¹ Surgery and ² Pathology, Brigham and Women's Hospital, Boston, Massachusetts

Requests for reprints: Monica M. Bertagnolli, Department of Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115. Phone: 617-732-8991; Fax: 617-582-6177; E-mail: mbertagnolli{at}partners.org.

Estrogen replacement therapy in postmenopausal women is associated with a reduction in colorectal cancer risk, potentially via interactions between 17ß-estradiol (E₂) and the estrogen receptors (ER) and ß. To study the role of E₂ in intestinal tumor inhibition, we separately crossed C57BL/6J-Min/+ (Min/+) mice with Er^+/– and Erß^+/– mice to generate ER-deficient Min/+ progeny. We found an increased incidence of visible colon tumors and dysplastic microadenomas in ER-deficient Min/+ relative to Er^+/+Min/+ controls. Small intestinal tumor numbers were unaffected. Invasive carcinomas were found only in Er^+/–Min/+ mice, suggesting that ER plays additional non–cell autonomous roles that limit tumor progression. Histologic analyses of ER-deficient Min/+ colons, as well as colons from ovariectomized Min/+ mice (OvxMin/+) and E₂-treated OvxMin/+ mice (OvxMin/+ +E₂), revealed significant differences in crypt architecture, enterocyte proliferation, and goblet cell differentiation relative to Min/+ and Er^+/+Apc^+/+ (wild-type) controls. The expression of ER and ERß was regionally compartmentalized along the colonic crypt axis, suggesting functional antagonism. Our results indicate that ER and ERß are inhibitory modifiers of Apc-dependent colon tumorigenesis. As a result, loss of E₂ and ER signaling in postmenopausal women may contribute to colorectal cancer development. [Cancer Res 2007;67(5):2366–72]

This article has been cited by other articles:

				F. O'Mahony, W. Thomas, and B. J. Harvey Novel female sex-dependent actions of oestrogen in the intestine J. Physiol., November 1, 2009; 587(21): 5039 - 5044. [Abstract] [Full Text] [PDF]

				A. G. Cleveland, S. I. Oikarinen, K. K. Bynote, M. Marttinen, J. J. Rafter, J.-A. Gustafsson, S. K. Roy, H. C. Pitot, K. S. Korach, D. B. Lubahn, et al. Disruption of estrogen receptor signaling enhances intestinal neoplasia in ApcMin/+ mice Carcinogenesis, September 1, 2009; 30(9): 1581 - 1590. [Abstract] [Full Text] [PDF]

				P. Protiva, H. S. Cross, M. E. Hopkins, E. Kallay, G. Bises, E. Dreyhaupt, L. Augenlicht, M. Lipkin, M. Lesser, E. Livote, et al. Chemoprevention of Colorectal Neoplasia by Estrogen: Potential Role of Vitamin D Activity Cancer Prevention Research, January 1, 2009; 2(1): 43 - 51. [Abstract] [Full Text] [PDF]

				N. B. Janakiram, V. E. Steele, and C. V. Rao Estrogen Receptor-{beta} as a Potential Target for Colon Cancer Prevention: Chemoprevention of Azoxymethane-Induced Colon Carcinogenesis by Raloxifene in F344 Rats Cancer Prevention Research, January 1, 2009; 2(1): 52 - 59. [Abstract] [Full Text] [PDF]

				S.-H. Chung, K. Wiedmeyer, A. Shai, K. S. Korach, and P. F. Lambert Requirement for Estrogen Receptor {alpha} in a Mouse Model for Human Papillomavirus-Associated Cervical Cancer Cancer Res., December 1, 2008; 68(23): 9928 - 9934. [Abstract] [Full Text] [PDF]

				A. P. Martin, A. Miller, L. Emad, M. Rahmani, T. Walker, C. Mitchell, M. P. Hagan, M. A. Park, A. Yacoub, P. B. Fisher, et al. Lapatinib Resistance in HCT116 Cells Is Mediated by Elevated MCL-1 Expression and Decreased BAK Activation and Not by ERBB Receptor Kinase Mutation Mol. Pharmacol., September 1, 2008; 74(3): 807 - 822. [Abstract] [Full Text] [PDF]

				A. P. Kouzmenko, K.-i. Takeyama, Y. Kawasaki, T. Akiyama, and S. Kato Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli. Genes Cells, July 1, 2008; 13(7): 723 - 730. [Abstract] [Full Text] [PDF]

				M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, T. E. Rohan, J. E. Manson, B. V. Howard, J. Wylie-Rosett, G. L. Anderson, G. Y.F. Ho, et al. Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal Women Cancer Res., January 1, 2008; 68(1): 329 - 337. [Abstract] [Full Text] [PDF]

				T. Hinoi, A. Akyol, B. K. Theisen, D. O. Ferguson, J. K. Greenson, B. O. Williams, K. R. Cho, and E. R. Fearon Mouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic Apc Inactivation Cancer Res., October 15, 2007; 67(20): 9721 - 9730. [Abstract] [Full Text] [PDF]